NFKB1 and diabetic encephalopathy: Previous study has demonstrated that the inhibition of mTOR/NF-κB pathway could ameliorate neuroinflammation, synaptic damage, and other symptoms associated with diabetic encephalopathy (Xu et al., 2021).